Literature DB >> 8435444

Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical properties.

R Callaghan1, A Stafford, R M Epand.   

Abstract

Growth of CHRC5 multidrug resistant cells in media enriched in a saturated C-17 fatty acid, heptadecanoic acid, resulted in these cells accumulating vinblastine at a rate and to an extent comparable to that of the parental cell line AB1. The fatty acid-enriched growth media had no effect on the ability of AB1 cells to take up vinblastine. The action of amphiphiles on the uptake of rhodamine dyes by CHRC5 cells was compared with the increased dye accumulation affected by verapamil. Membrane rigidifying agents, such as the saturated fatty acid stearic acid, or the cholesterol derivatives, cholesteryl hemisuccinate and cholesteryl phosphorylcholine, as well as a membrane fluidizing unsaturated fatty acid, linoleic acid, could significantly increase dye uptake, although not as well as verapamil. These results taken in conjunction with other reports in the literature, demonstrate that multidrug resistance is sensitive to alterations of membrane properties. They suggest that perturbation of the membrane to either increased or to decreased membrane fluidity can lower the level of resistance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435444     DOI: 10.1016/0167-4889(93)90217-d

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

Review 1.  In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.

Authors:  Altug Ozcelikkale; Hye-Ran Moon; Michael Linnes; Bumsoo Han
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-14

2.  Characteristics of the binding of tacrine to acidic phospholipids.

Authors:  J Y Lehtonen; M Rytömaa; P K Kinnunen
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

Review 3.  Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles.

Authors:  Chiranjeevi Peetla; Sivakumar Vijayaraghavalu; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2013-09-19       Impact factor: 15.470

Review 4.  Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.

Authors:  Bumsoo Han; Chunjing Qu; Kinam Park; Stephen F Konieczny; Murray Korc
Journal:  Cancer Lett       Date:  2015-12-10       Impact factor: 8.679

5.  An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.

Authors:  Brendan M Johnson; William N Charman; Christopher J H Porter
Journal:  AAPS PharmSci       Date:  2002

6.  Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability.

Authors:  I K Pajeva; M Wiese; H P Cordes; J K Seydel
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

7.  Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.

Authors:  Hui Xin Ong; Daniela Traini; Mary Bebawy; Paul M Young
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

8.  Multi drug resistance-dependent "vacuum cleaner" functionality potentially driven by the interactions between endocytosis, drug size and Pgp-like transporters surface density.

Authors:  Cyril Rauch; Alain Pluen
Journal:  Eur Biophys J       Date:  2007-01-09       Impact factor: 2.095

9.  Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma.

Authors:  P Bougnoux; E Germain; V Chajès; B Hubert; C Lhuillery; O Le Floch; G Body; G Calais
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  Selective modulation of P-glycoprotein-mediated drug resistance.

Authors:  M Bebawy; M B Morris; B D Roufogalis
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.